Egaba 25 mg (Capsule)
Unit Price: ৳ 8.00 (3 x 10: ৳ 240.00)
Strip Price: ৳ 80.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Pregabalin |
| Company | Euro pharma ltd |
| Also available as |
Indications
- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
- Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
- Fibromyalgia
- Neuropathic pain associated with spinal cord injury
Pharmacology
- Structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA)
- Binds with high affinity to the alpha2-delta site in central nervous system tissues
- Anti-nociceptive and antiseizure effects
Dosage
- Recommended dose for Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Recommended dose for Postherpetic neuralgia (PHN)
- Recommended dose for Management of fibromyalgia
- Recommended dose for Neuropathic pain associated with spinal cord injury
- Dosage conversion from Pregabalin capsules to Pregabalin CR capsule tablet
Administration
- Route of administration: oral
- Pregabalin CR tablet should be administered after an evening meal
- Swallowed whole and should not be split, crushed or chewed
Interaction
- Unlikely to be involved in significant pharmacokinetic drug interactions
Contraindications
- Contraindicated in patients with known hypersensitivity to Pregabalin or any of its components
Side Effects
- Common side effects in adults
- Common side effects in pediatric patients for the treatment of partial onset seizures
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- Small amounts detected in the milk of lactating women
- Breastfeeding not recommended during treatment
Precautions & Warnings
- Angioedema and hypersensitivity reactions
- Increased risk of suicidal thoughts or behavior
- Respiratory depression
- Impact on driving or operating machinery
- Seizure frequency and adverse reactions upon rapid discontinuation
- Peripheral edema
- Cautions when coadministering with thiazolidinedione antidiabetic agents
Use in Special Populations
- Safety and effectiveness in pediatric patients
- Safety and effectiveness in pediatric patients below the age of 1 month
- Safety and effectiveness of Egaba extended-release tablet in pediatric patients
Overdose Effects
- Signs and symptoms of overdose
- No specific antidote
- General supportive care
Therapeutic Class
- Adjunct anti-epileptic drugs
- Primary anti-epileptic drugs
Storage Conditions
- Keep in a cool & dry place (below 30°C)
- Protected from light & moisture
- Keep out of the reach of children
Chemical Structure
- Molecular Formula: C8H17NO2
Common Questions about Egaba 25 mg Capsule
- Description of Egaba 25 mg Capsule
- Duration of use for seeing improvement
- Frequency of use
- Instructions for storage and disposal
- Varied effectiveness for different diseases
- Duration of use
- Necessity to continue use even if feeling fine
- Possibility of using another medication with Egaba 25 mg Capsule
- Possibility of weight gain
- Quick tips for usage